v3.26.3
Net Loss Per Share
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
 
The following table is a reconciliation between net loss and the amounts used to compute basic and diluted net loss per share and the weighted average shares outstanding used to compute basic and diluted net loss per share. Potentially dilutive securities include shares issuable upon conversion of our 3.125% Convertible Senior Notes using the if-converted method and restricted stock unit awards under our equity-based compensation plan.
Three Months EndedNine Months Ended
September 30,September 30,
2026202520262025
(In thousands, except per share data)
Numerator:
Net loss allocable to common stockholders$(43,010)$(124,299)$(83,809)$(322,645)
Denominator:
Weighted average number of shares outstanding:
Basic 595,470 478,254 565,363 477,344 
Restricted stock units(1)— — — — 
Shares issuable assuming conversion of 3.125% Convertible Senior Notes(2)
— — — — 
Diluted 595,470 478,254 565,363 477,344 
Net loss per share:
Basic $(0.07)$(0.26)$(0.15)$(0.68)
Diluted $(0.07)$(0.26)$(0.15)$(0.68)
__________________________________
(1)We excluded restricted stock units of 14.9 million and 5.4 million for the three months ended September 30, 2026 and 2025, respectively, and 14.4 million and 5.7 million for the nine months ended September 30, 2026 and 2025, respectively from the computations of diluted net loss per share because the effect would have been anti-dilutive.
(2)Represents the dilutive impact for the Company’s 3.125% Convertible Senior Notes due 2030. As of September 30, 2026, the if-converted value is less than the outstanding principal of the 3.125% Convertible Senior Notes and therefore anti-dilutive. The 3.125% Convertible Senior Notes are subject to a capped call arrangement that potentially reduces the dilutive effect. Any potential impact of the capped call arrangement is excluded from this table as any proceeds under the capped call arrangement are considered anti-dilutive.

In March 2026, the Company completed a registered underwritten public offering of 112.1 million shares of common stock, par value $0.01, resulting in net proceeds to Kosmos of approximately $206.4 million.